Effects of acupuncture and moxibustion in a mouse model of allergic rhinitis

Otolaryngology - Head and Neck Surgery

Volumn 146, Issue 1, 2012, Pages 19-25

  Jung, Dallim ^a   Lee, Seungdeok ^b   Hong, Seungug ^a,b  

^a Dongguk University   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Acupuncture; Allergic rhinitis; Inducible nitric oxide synthase (iNOS); Moxibustion; Nuclear factor kappa B (NF B); Signal transducer and activator of transcription 6 (STAT6); Substance P

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LEVOCETIRIZINE; OVALBUMIN; STAT6 PROTEIN; SUBSTANCE P; BIOLOGICAL MARKER; NF KAPPA B KINASE; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; STAT6 PROTEIN, MOUSE;

ACUPUNCTURE; ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MOUSE; MOXIBUSTION; NONHUMAN; NOSE MUCOSA; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; DISEASE MODEL; METABOLISM; METHODOLOGY; PERENNIAL RHINITIS; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MOXIBUSTION; NASAL MUCOSA; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN-SERINE-THREONINE KINASES; RHINITIS, ALLERGIC, PERENNIAL; STAT6 TRANSCRIPTION FACTOR; SUBSTANCE P; TREATMENT OUTCOME;

EID: 84863345180     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811421736     Document Type: Article

References (27)

1. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108:S2-S8.
2. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758-764. (Pubitemid 39504428)
3. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol. 2004;114:S135-S138. (Pubitemid 39440924)
4. Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55:116-134. (Pubitemid 30106016)
5. MacPherson H, Thomas K, Walters S, Fitter M. The York Acupuncture Safety Study: prospective survey of 34 000 treatments by traditional acupuncturists. BMJ. 2001;323:486-487. (Pubitemid 32822288)
6. White A. The safety of acupuncture: evidence from the UK. Acupunct Med. 2006;24:53-57.
7. Liu Z, Liu L. Essentials of Chinese Medicine: Clinical Fundamentals in Chinese Medicine. Vol 2. New York, NY: Springer; 2009.
8. Roberts J, Huissoon A, Dretzke J, Wang D, Hyde C. A systematic review of the clinical effectiveness of acupuncture for allergic rhinitis. BMC Complement Altern Med. 2008;8:13.
9. Xiao L, Li B, Du YH, Xiong J, Gao X. Systematic evaluation of the randomized controlled trials about acupuncture and moxibustion treatment of allergic rhinitis. Zhongguo Zhen Jiu. 2009;29:512-516.
10. Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care. Am J Epidemiol. 2009;169:562-571.
11. da Silva MD, Guginski G, de Paula Werner MF, Baggio CH, Marcon R, Santos ARS. Involvement of interleukin-10 in the anti-inflammatory effect of Sanyinjiao (SP6) acupuncture in a mouse model of peritonitis. Evid Based Complement Altern Med. 2011;2011:217946.
12. Tamura K, Arakawa H, Suzuki M, et al. Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases. Clin Exp Allergy. 2001;31:1509-1514. (Pubitemid 32939456)
13. Alberty J, August C, Stoll W, Rudack C. The effect of endogenous nitric oxide on cholinergic ciliary stimulation of human nasal mucosa. Laryngoscope. 2004;114:1642-1647. (Pubitemid 39278886)
14. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705-4708. (Pubitemid 24239438)
15. Lundberg JM, Hokfelt T, Martling CR, Saria A, Cuello C. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res. 1984;235:251-261. (Pubitemid 14189762)
16. Hanf G, Schierhorn K, Brunnee T, Noga O, Verges D, Kunkel G. Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis. Inflamm Res. 2000;49:520-523.
17. Saito H, Howie K, Wattie J, et al. Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis. Immunology. 2001;104:226-234. (Pubitemid 32989523)
18. Shen X, Ding G, Wei J, et al. An infrared radiation study of the biophysical characteristics of traditional moxibustion. Complement Ther Med. 2006;14:213-219. (Pubitemid 44185034)
19. Al Suleimani YM, Walker MJ. Allergic rhinitis and its pharmacology. Pharmacol Ther. 2007;114:233-260. (Pubitemid 46843251)
20. Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med. 2001;193:1087-1096. (Pubitemid 32436202)
21. Izuhara K, Shirakawa T. Signal transduction via the interleukin-4 receptor and its correlation with atopy. Int J Mol Med. 1999;3:3-10.
22. Barnes PJ. Nitric oxide and airway disease. Ann Med. 1995;27:389-393.
23. Koarai A, Ichinose M, Sugiura H, Yamagata S, Hattori T, Shirato K. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm Pharmacol Ther. 2000;13:267-275.
24. Zijlstra FJ, van den Berg-de Lange I, Huygen FJ, Klein J. Anti-inflammatory actions of acupuncture. Mediators Inflamm. 2003;12:59-69. (Pubitemid 36783244)
25. Lee JI, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol. 1998;38:981-993. (Pubitemid 28524444)
26. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol. 2001;2:45-50. (Pubitemid 33704952)
27. Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol. 1993;92:95-104. (Pubitemid 23234089)